The ISGIDAR NEWSLETTER
VOL. 23, NO. 1
March, 1997
INTERNATIONAL STUDY GROUP INVESTIGATING DRUGS AS REINFORCERS
CORRESPONDENCE ABOUT
ISGIDAR:
(President of ISGIDAR) | ABOUT ISGIDAR NEWSLETTER:
(Secretary of ISGIDAR) |
R. J. Lamb
DART (MS 984)
Medical College of Pennsylvania and
Hahnemann University
Department of Psychiatry
Broad & Vine Streets
Philadelphia, PA 19102-1192
tel: (215) 762-8387
email: lambr@allegheny.edu
| Patrick M. Beardsley, Ph.D.
Medical College of Virginia
Department of Pharmacology & Toxicology
P. O. Box 980613
410 N. 12th St., Smith Bld. #756A
Richmond, VA 23298-0613
tel: (804) 828-5185
email: PBEARDSLEY@GEMS.VCU.EDU | |
1997 ISGIDAR SCIENTIFIC MEETING -- NASHVILLE, TENNESSEE
The 1997 annual ISGIDAR Scientific Meeting will be held Saturday 14 June 1997 at the Opryland Hotel in Nashville, Tennessee. As usual, the meeting will be held as a satellite session immediately preceding the annual scientific meeting of the College on Problems of Drug Dependence. ISGIDAR registration will begin at 8:30 am. The registration fee is $25. Paper presentations will be scheduled between 9 am and 5 pm, and the business meeting will be held from 5 to 5:30 pm. The 1997 program is available here.
The business meeting should be particularly important this year for there are issues that will need discussion. One issue involves the date and time, relative to the CPDD meetings as a whole, during which ISGIDAR meets each year. Many of our most senior ISGIDAR members often can't attend our annual meeting because they are on the CPDD board which often has its sessions contemporaneous with those of ISGIDAR. Other members with interests in nicotine self-administration will have difficulties because the SRNT meetings, this year also a satellite of the CPDD meetings, overlap with those of ISGIDAR. In the past, members with interests in cannabinoid pharmacology had problems as well trying to shuffle between the Cannabis Society meetings and ISGIDAR. Is there a better time for us to hold our meetings and maximize our attendance? Other issues regards our luncheon and whether changing the price or venue could facilitate attendance at it. Finally, issues regarding whether we should seek a journal to publish the ISGIDAR meeting abstracts remain; would publishing the abstracts within the ISGIDAR Newsletter be satisfactory? Please think about these issues for your opinion, if not your vote, will be requested at the business meeting.
To present a paper at the ISGIDAR meeting, please send an abstract by May 1, 1997 to Rick Lamb at the address listed above. Abstracts should conform to the format used for presentations at CPDD. Please note that papers submitted to ISGIDAR should not also be presented at CPDD. The amount of time available for each talk will depend on the number of papers submitted but will not be less than 20 minutes.
1997 ISGIDAR Lunch
We are again arranging to have lunch catered by the hotel, so that we can eat together and continue discussions from the morning session. The lunch will cost about $15 per person. Because in past years we have had difficulty estimating the number of people wanting lunch, which has resulted in some cases in large drains in the ISGIDAR treasury and in other cases in pleading and begging with hotel staff, we are asking that those wishing to join us for the ISGIDAR lunch indicate in advance, preferably by email (but you can use snail mail or fax if need be), to Rick Lamb at the address below. Please let the various members of your lab who will be attending ISGIDAR, but who might not receive the Newsletter, know about lunch. While there will be a limited number of seats available for those failing to indicate in advance their desire for lunch, these will be strictly limited and will be available on a first come first serve basis.
For Luncheon Reservations:
R. J. Lamb
DART (MS 984)
Medical College of Pennsylvania and
Hahnemann University
Department of Psychiatry
Broad & Vine Streets
Philadelphia, PA 19102-1192
tel: (215) 762-8387
fax: (215) 246-5290
email: lambr@allegheny.edu
|
If you wish, you may also advance register ($25) by sending a check to Marilyn Carroll at the address below. Receipts for meal costs (and registration) will be provided at the meeting.
Submit advanced registration payable to ISGIDAR to:
Dr. Marilyn Carroll
Psychiatry Department
Box 392 UMHC
University of Minnesota
Minneapolis, MN 55455 |
NOMINATIONS FOR ISGIDAR MEMBERSHIP
Everyone is encouraged to submit nominations for ISGIDAR membership to the president at the address on the front of the newsletter. New members are essential to maintaining ISGIDAR as a vigorous organization. A letter of recommendation and vita are needed to be considered.
Nominations for membership
| Candidate | Institution | Sponsor |
| ERIC DONNY | Univ. of Pittsburgh | Kenneth A. Perkins, Ph.D. |
| JEFFERY KIRK | Univ. of Chicago | Harriet de Wit, Ph.D. |
| STEPHEN WACHTEL | Univ. of Chicago | Harriet de Wit, Ph.D. |
| ANDREW MORRAL | Allegheny Univ. of Hlth Sci. | Richard J. Lamb, Ph.D. |
1997 TRAVEL AWARD: STUDENT PAPER COMPETITION
Student Travel Award
ISGIDAR will again sponsor a Student Paper Competition Award for a new investigator to present a paper on drug self-administration research. Up to $500 in reasonable and documented travel costs will be paid to the winner to present a paper at ISGIDAR. Payment will be made upon submission of travel receipts to the ISGIDAR Treasurer. Those who do not receive the award, but who receive good reviews will be encouraged to present their papers at the ISGIDAR meeting.
ELIGIBILITY: Applicants must be enrolled in a graduate program and be working toward a doctorate or have received their doctorate within the last five years (after June 1, 1992).
Applicants who are not ISGIDAR members must be sponsored by an ISGIDAR member.
The research to be reported at ISGIDAR must not already be published.
MANUSCRIPT REQUIREMENTS: Papers should not be more than 10 pages excluding figures and references.
The length and scope of the paper should be consistent with a 20-25 minute slide presentation.
Please include paper title, name, address, phone number and author's signature on the cover page of the manuscript. The signature and typed name of the author's sponsor should also appear on the cover page after a statement indicating that the applicant made a significant scientific contribution to the research. Submit four copies, double-spaced.
REVIEW: Each manuscript will be independently reviewed by the ISGIDAR officers for originality, scientific contribution, methodology and clarity. Blind review is possible upon request. Reviewers will not participate in the review of papers from their own institution.
Submit manuscripts to
R. J. Lamb
DART (MS 984)
Department of Psychiatry
Medical College of Pennsylvania and
Hahnemann University
Broad & Vine Streets
Philadelphia, PA 19102
DEADLINE FOR SUBMISSION: May 1, 1997
POST-DOCTORAL POSITIONS AND FELLOWSHIPS
MEDICAL COLLEGE OF VIRGINIA, DEPARTMENT OF PHARMACOLOGY Postdoctoral research positions are available in laboratory animal behavioral pharmacology. Positions are possible utilizing almost any behavioral pharmacological approach to the study of the behavioral and/or neurochemical mechanisms mediating the activity of the drugs of abuse. Ongoing studies utilize mice, rats, squirrel monkeys, and rhesus monkeys in discrimination, self-administration, and other operant and respondent procedures involving all routes of systemic and central drug administration. Of particular current emphasis are studies involving the:
- pharmacology of excitatory amino acid agents
- development of medications for the treatment of drug-dependency disorders
- pharmacology of behaviorally-active inhalation agents
- development of drug relapse procedures synthesizing operant and respondent
methodologies
Many opportunities exist for collaborating with other researchers in the department who have major research foci upon the stimulants and hallucinogens, cannabinoids, nicotine, and the opiates. Send vita, letter of interest, and names and telephone numbers of 2 references to: Patrick M. Beardsley, Ph.D. or Robert L. Balster, Ph.D.; Medical College of Virginia, Department of Pharmacology, P.O. Box 980613, Richmond, VA 23298-0613. (804) 828-5185.
POST-DOCTORAL POSITION IN NICOTINE/SMOKING RESEARCH A post-doctoral position is anticipated in nicotine/smoking research with Dr. Kenneth A. Perkins at the University of Pittsburgh. This research centers on the behavioral pharmacology of nicotine in humans. NIDA-supported projects include the relationships of nicotine discrimination and tolerance to tobacco dependence and self-administration. Applicants also interested in clinical research may become involved in smoking cessation studies. Interested candidates should send a C.V. and letter of interest to Dr. Perkins at the following address: Kenneth A. Perkins, Ph.D. Department of Psychiatry, University of Pittsburgh Medical Center, 3811 O'Hara Street
Pittsburgh, PA 15213
Job Opening Research Associate, Department of Psychiatry, University of Mississippi Medical Center. Develop, implement and publish research relating to thebehavioral neuropharmacology of abused drugs, particularly drugself-administration and drug discrimination in non-human primates. Therelationship between in vitro or in vivo neuropharmacology and behavioraleffects is of central interest. Ph.D. in pharmacology or neurosciencerequired. Salary commensurate with experience; could be anywhere from 0 to3 years post-doc. Send c.v. and names of three references to: William L.Woolverton, Ph.D., Department of Psychiatry and Human Behavior, TheUniversity of Mississippi Medical Center, 2500 N. State Street, Jackson,MS, 39216. EOE, M/F/D/V.
Postdoctoral Research Fellowship in substance abuse One position is available in a stimulating productive laboratory. Responsibilities are in the behavioral economics of drug self-administration. Applicants must have completed doctoral training in psychology or pharmacology and have research experience. Minorities are encouraged to apply. Competitive stipends. Send letters of interest, vita, and letters of reference to Warren K. Bickel, Ph.D., Human Behavioral Pharmacology Laboratory, Department of Psychiatry, 38 Fletcher Place, Burlington, Vermont 05401-1419.
BIBLIOGRAPHY
This is a listing of recent (within the last 12 mos) publications on drug reinforcement or on the behavioral pharmacology of drugs of abuse submitted by ISGIDAR members: RA=reprint available; IP=in press; NA=reprint not available.
William L. Woolverton, Ph.D., Professor and Director
Division of Neurobiology and Behavior Research
Department of Psychiatry and Human Behavior
University of Mississippi Medical Center
2500 N. State Street Jackson, MS 39216
phone: 601-984-5898 FAX: 601-984-5899
- Rowlett, J.K., Massey, B.W., Kleven, M.S. and Woolverton,
W.L.: Parametric analysis of cocaine self-administration under a progressive-ratio
schedule inrhesus monkeys. Psychopharmacology 125: 361-370, 1996. (RA)
- IP Woolverton, W.L.: Intravenous self-administration of cocaine under concurrent VI schedules of reinforcement. Psychopharmacology, 127:195-203, 1996. (IP)
- IP Rowlett, J.K. and Woolverton, W.L.: Assessment of benzodiazepine receptor heterogeneity in vivo: Apparent pA2 and pKb analyses from behavioral studies. Psychopharmacology, 128: 1-16, 1996. (IP)
John D. Roache, Ph. D.
UT Psychiatry - Houston
Department of Psychiatry and Behavioral Sciences
UT Mental Science Institute
1300 Moursund
Substance Abuse Research Center
Houston, TX 77030
- Roache, JD, Stanley, MA, Creson, DL, Meisch, A, and Shah, NN. Diazepam reinforcement in anxious patients. Experimental and Clinical Psychopharmacology 4:308-314, 1996. (RA)
- Spiga, R. and Roache, JD. Human drug self-administration: A review and methodological critique. In: Drug Addiction and its Treatment: Nexus of Neuroscience and Behavior. Johnson, BA and Roache, JD (eds.) Lippincott-Raven Publishers, Philadelphia, pp. 39-71, 1997. (RA)
- Roache, JD, Stanley, MA, Creson, DL, Shah, NN, and Meisch, RA. Alprazolam-reinforced medication use in outpatients with anxiety. Drug and Alcohol Dependence. (IP)
- Spiga, R., Macenski, MJ, Meisch, RA, and Roache, JD. Human ethanol self-administration I: The interaction between response requirement and ethanol dose. Behavioral Pharmacology. (IP)
Robert L. Balster, Ph.D.
Medical College of Virginia
Department of Pharmacology & Toxicology
P.O. Box 980613
Richmond, VA 23298-0613
- Locke, K.W. Levesque, T.R., Nicholson, K.L. and Balster, R.L. Dexfenfluramine lacks amphetamine-like abuse potential. Progress in Neuro-Psychopharmacology and Biological Psychiatry 20:1019-1035, 1996. (NA)
- Gold, L.H. and Balster, R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 126:286-292, 1996. (RA)
- Beardsley, P.M., Balster, R.L. and Harris, L.S. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology 127:315-322, 1996.
John Hughes, M.D.
Department of Psychiatry
University of Vermont
38 Fletcher Place
Burlington, VT 05401-1419
- Bickel WK, DeGrandpre RJ, Higgins ST, Hughes JR, Badger GJ (1995): Effects of simulated employment and recreation on drug taking: A behavioral economic analysis. Exp Clin Psychopharm 3:467-476.
- Hale KL, Hughes JR, Oliveto AH, Higgins ST (1995): Caffeine self-administration and subjective effects in adolescents. Exp Clin Psychopharm 3:364-370.
- Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ (1995): The ability of low doses of caffeine to serve as reinforcers in humans: A replication. Exp Clin Psychopharm 3:358-363.
- Hughes JR, Oliveto AH, Higgins ST, Bickel WK, Terry SY (1996): Saying vs doing and other methodological issues in the study of human drug self-administration. Exp Clin Psychopharm 4:234-238.
ISGIDAR BIBLIOGRAPHY SUBMISSIONS
The pressroom of the ISGIDAR Newsletter encourages submission of recent (preferably during the last 12 months) references from its membership. References should be submitted only electronically either by diskette mailed to the address below or via email (a bin hex attachment works fine) to PBEARDSLEY@GEMS.VCU.EDU. Please send references in a format akin to JPET format. Almost any word processing file format (PC or Mac) is digestible.
Thanks,
For ISGIDAR BIBLIOGRAPHY SUBMISSIONS, please transmit references to:
Patrick M. Beardsley, Ph.D.
Medical College of Virginia
Department of Pharmacology & Toxicology
P. O. Box 980613
410 N. 12th St., Smith Bld. #756A
Richmond, VA 23298-0613
tel: (804) 828-5185
email: PBEARDSLEY@GEMS.VCU.EDU | |
|